✦ LIBER ✦

Phase II Trial of Hydroxyurea, Dacarbazine (DTIC), and Etoposide (VP-16) in Mixed Mesodermal Tumors of the Uterus: A Gynecologic Oncology Group Study

✍ Scribed by John L. Currie; John A. Blessing; Ramon McGehee; John T. Soper; Michael Berman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of ifosfamide and mesna i

✍ Sutton, Gregory P.; Blessing, John A.; Rosenshein, Neil; Photopulos, Guy; DiSaia 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 491 KB

Phase II Evaluation of Oral Trimetrexate

✍ Jeffrey M. Fowler; John A. Blessing; Robert A. Burger; John H. Malfetano 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Combination Chemotherapy with Hydroxyure

✍ John L. Currie; John A. Blessing; Hyman B. Muss; Jeffrey Fowler; Michael Berman; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Phase II Trial of Etoposide in Leiomyosa

✍ Tate Thigpen; John A. Blessing; Edgardo Yordan; Fidel Valea; Luis Vaccarello 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Phase II Trial of Paclitaxel in Leiomyos

✍ Gregory Sutton; John A. Blessing; Harrison Ball 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Phase II trial of ifosfamide and mesna i

✍ Sutton, Gregory P.; Blessing, John A.; Barrett, Rolland J.; McGehee, Ramon 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 409 KB